Interspecies considerations in the evaluation of human food safety for veterinary drugs

AAPS PharmSci

Volumn 4, Issue 4, 2002, Pages

  Craigmill, Arthur L ^a   Cortright, Kristy A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comparative; Food safety; Metabolism; Residues

Indexed keywords

DRUG METABOLITE; DRUG RESIDUE; FENBENDAZOLE; IVERMECTIN; VETERINARY DRUG; XENOBIOTIC AGENT;

CAT; CHICKEN; COMPARATIVE STUDY; COW; DOG; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDICATION; DRUG METABOLISM; DRUG TISSUE LEVEL; DRUG UTILIZATION; ENVIRONMENTAL EXPOSURE; FOOD AND DRUG ADMINISTRATION; FOOD SAFETY; HORSE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; RESIDUE ANALYSIS; REVIEW; RISK ASSESSMENT; SPECIES DIFFERENCE; TURKEY (BIRD); ANIMAL; ARTICLE; FOOD ANALYSIS; HUMAN; METABOLISM;

ANIMALS; DRUG RESIDUES; FENBENDAZOLE; FOOD ANALYSIS; HUMANS; IVERMECTIN; SPECIES SPECIFICITY; VETERINARY DRUGS;

EID: 85046915196     PISSN: 15221059     EISSN: None     Source Type: Journal    
DOI: 10.1208/ps040434     Document Type: Review

References (45)

1. US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Veterinary Medicine. General principles for evaluating the safety of compounds used in food-producing animals. Washington, DC: US Government Printing Office; CVM Guideline #3, parts I-VIII. Revised July, 1994.
2. Friedlander LG, Brynes SD, Fernandez AH. The human food safety evaluation of new animal drugs. Vet Clin North Am Food Anim Pract. 1999;15:1-11.
3. Juskevich, JC. Comparative metabolism in food-producing animals: Programs sponsored by the Center for Veterinary Medicine. Drug Metab Rev. 1987;18:345-362.
4. Miwa GT, Walsh JS, VandenHeuvel WJA, et al. The metabolism of avermectins B1a, H2B1a, and H2B1b by liver microsomes. Drug Metab Dispos. 1982;10:268-274.
5. Chiu SHL, Buhs RP, Sestokas E, Taub R, Jacob TA. Determination of ivermectin residues in animal tissues by high-performance liquid chromatography-reverse isotope dilution assay. J Agric Food Chem. 1985;33:99-102.
6. Chiu SHL, Sestokas E, Taub R, et al. Metabolic disposition of ivermectin in tissues of cattle, sheep and rats. Drug Metab Dispos. 1986;14:590-600.
7. Chiu SHL, Taub R, Sestokas E, Lu AYH, Jacob TA. Comparative in vivo and in vitro metabolism of ivermectin in steers, sheep, swine and rat. Drug Metab Rev. 1987;18:289-302.
8. Chiu SHL, Carlin JR, Taub R, et al. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep and rats. Drug Metab Dispos. 1988;16:728-736.
9. Slanina P, Kuivinen J, Ohlse C, Ekstr. Ivermectin residues in the edible tissues of swine and cattle: effect of cooking and toxicological evaluation. Food Additive Contam. 1989;6:475-481.
10. Chiu SHL, Green M, Baylis FP, et al. Absorption, tissue distribution and excretion of tritium-labeled ivermectin in cattle, sheep and rat. J Agric Food Chem. 1990;38:2072-2078.
11. Chiu SHL, Sestokas E, Taub R, et al. Metabolic disposition of ivermectin in swine. J Agric Food Chem. 1990;38:2079-2085.
12. Ferguson DL. Target Animal Safety (6/5/84 - 7/12/84). Rockville, MD: Center for Veterinary Medicine, Food and Drug Administration; 1989. Public Master File 3883.
13. Steel JW. Pharmacokinetics and metabolism of avermectins in livestock. Vet Parasitol. 1993;48:45-57.
14. Short CR, Barker SA, Hsieh LC, et al. Disposition of fenbendazole in the goat. Am J Vet Res. 1987;48:811-815.
15. Short CR, Flory W, Hsieh LC, Barker SA. The oxidative metabolism of fenbendazole: a comparative study. J Vet Pharmacol Ther. 1988;11:50-55.
16. Short CR, Barker SA, Flory W. Comparative drug metabolism and disposition in minor species. Vet Hum Toxicol. 1988;30 (suppl 1):2-8.
17. Payne MA, Craigmill AL, Riviere JE, Webb AI, Baynes RE, Sundlof SF. The Food Animal Residue Avoidance Databank (FARAD): Past, Present and Future. Vet Clin North Am Food Anim Pract. 1999;15:75-88.
18. Craigmill AL, Sundlof SF, Riviere, JE. The role of the Food Animal Residue Avoidance Databank (FARAD) in food contamination, mitigation and prevention. Proceedings of the 4th Congress of the European Association for Veterinary Pharmacology and Toxicology, Budapest, August 28-September 2, 1988. In: Simon, Lees, Semj eds. Veterinary Pharmacology Toxicology and Therapy in Food Producing Animals, University of Veterinary Science, Budapest;1990:255-258.
19. Payne MA, Kleinschmidt LA, Craigmill AL. Environmental Contamination in Food Animals: Information Resources [abstract Q18]. Proceedings of the 8th International Congress of the European Association for Veterinary Pharmacology and Toxicology [CD-ROM]. Jerusalem, Israel; July 30-August 3, 2000.
20. Martin-Jimenez T, Baynes RE, Craigmill A, Riviere JE. Extrapolated Withdrawal-Interval Estimator (EWE) Algorithm: A quantitative approach to establish extrapolated withdrawal times. Regul Toxicol Pharm. In press.
21. Ringer RK, Miller LR, Saylor WW. Minor-use animal drug program-a national agricultural program to approve animal drugs for minor species and uses. JAVMA. 1999;214:1636-1637.
22. Greenlees KJ, Bell TA. Aquaculture crop grouping and new animal drug approvals: a CVM perspective. Vet Hum Toxicol. 1998;40(suppl):219-223.
23. Gingerich WH, Stehly GR, Clark KJ, Hayton WL. Crop grouping: a proposal for public aquaculture. Vet Hum Toxicol. 1998;40(suppl):224-231.
24. Riviere JE. Comparative Pharmacokinetics: Principles, Techniques, and Applications. Ames, IA: Iowa State University Press; 1999.
25. Riviere JE, Mart Jimz T, Sundlof SF, Craigmill AL. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. J Vet Pharmacol Ther. 1997;20:453-463.
26. Mart Jimz T, Riviere, JE. Mixed effect modeling of the disposition of gentamicin across domestic animal species. J Vet Pharmacol Ther. 2001;24:321-332.
27. Mart Jimz T, Riviere JE. Mixed effect modeling of the interspecies pharmacokinetic scaling of oxytetracycline. J Pharm Sci. 2002;91:331-341.
28. Riond JL, Riviere JE. Allometric analysis of doxycycline pharmacokinetic parameters. J Vet Pharmacol Therap.1990;12:253-260.
29. Mahmood I. Interspecies scaling: is a priori knowledge of cytochrome p450 isoenzymes involved in drug metabolism helpful in prediction of clearance in humans from animal data? Drug Metabol Drug Interact. 2001;18:135-147.
30. Dalvi RR, Nunn VA, Juskevich J. Studies on comparative drug metabolism by hepatic cytochrome P-450 containing microsomal enzymes in quail, ducks, geese, chickens, turkeys and rats. Comp Biochem Physiol. 1987;87C:421-424.
31. Dalvi RR, Nunn VA, Juskevich J. Hepatic cytochrome P-450 dependent drug metabolizing activity in rats, rabbits and several food-producing species. J Vet Pharmacol Ther. 1987;10:164-168.
32. Dalvi RR. Comparative in vitro and in vivo drug metabolism in major and minor food producing species. Vet Hum Toxicol. 1988;30(suppl 1):22-25.
33. de Kanter R, Monshouwer M, Meijer DK, Groothuis GM. Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues. Curr Drug Metab. 2002;3(1):39-59.
34. Venkatakrishnan K, Von Moltke LL, Greenblatt DJ. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models. J Clin Pharmacol. 2001; 41 (11):1149-1179.
35. Bachmann KA, Ghosh R. The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions. Curr Drug Metab. 2001;2(3):299-314.
36. Nebbia C, Ceppa L, Dacasto M, Nachtman C, Carletti M. Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats. J Vet Pharmacol Ther. 2001;24:399-403.
37. Gregus Z, Watkins JB, Thompson TN, Harvey MJ, Rozman K, Klaassen CD. Hepatic Phase I and Phase II biotransformations in quail and trout: comparison to other species commonly used in toxicity testing. Toxicol and Applied Pharmacol. 1983;67:430-441.
38. Gawai KR, Vodela JK, Dalvi PS, Dalvi RR. Comparative assessment of the effect of aflatoxin B1 on hepatic dysfunction in some mammalian and avian species. Comp Biochem Physiol C. 1992;101:415-418.
39. Leffin M, Riviere JL. Effects of some inducers on hepatic and extrahepatic drug metabolism in the mallard duck (Anas platyrynchos). Comp Biochem Physiol C. 1992;102:471-476.
40. Thabrew MI, Obasi SC, Emerole GO. Further studies on microsomal drug metabolizing enzyme activity and protein levels in animal models showing different susceptibilities to aflatoxicosis. Comp Biochem Physiol C. 1982;73:289-292.
41. Ronis MJJ, Ingelman-Sundberg M, Badger TM. Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). Biochem Pharmacol. 1994;48:1953-1965.
42. Klein PJ, Buckner R, Kelly J, Coulombe RA Jr. Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B1. Toxicol and Applied Pharmacol. 2000;165:45-52.
43. Giorgi M, Marini S, Longo V, Mazzaccaro A, Amato G, Gervasi PG. Cytochrome P450-dependent mono-oxygenase activities and their inducibility by classic P450 inducers in the liver, kidney, and nasal mucosa of male adult ring-necked pheasants. Toxicol and Appl Pharmacol. 2000;167:237-245.
44. Goeger DE, Anderson KE. Biochemical characterization of coumarin 7droxylase activity in chick embryo liver microsomes. Biochem Pharmacol. 1992;43:363-369.
45. Baynes RE, Martin-Jimenez T, Craigmill AL, Riviere JE. Estimating provisional acceptable residues for extralabel drug use in livestock. Regul Toxicol Pharmacol. 1999;29:287-299.